Ubs Oconnor LLC Deciphera Pharmaceuticals, Inc. Transaction History

Ubs Oconnor LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $460,036 - $588,087	33,876 Added 28.73%	151,796 $2.39 Million
Q4 2023 Feb 14, 2024	SELL	$10.11 - $16.54 $362,109 - $592,413	-35,817 Reduced 23.3%	117,920 $1.9 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $959,420 - $1.19 Million	77,000 Added 100.34%	153,737 $1.96 Million
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $1.02 Million - $1.22 Million	76,737 New	76,737 $1.08 Billion
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $159,640 - $247,409	11,195 Added 23.57%	58,695 $906,000
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $556,875 - $714,000	37,500 Added 375.0%	47,500 $0
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $123,800 - $202,300	10,000 New	10,000 $185 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.